Skip to Content

LU K72 (Quetiapine Fumarate Extended-Release 150 mg)

Pill with imprint LU K72 is White, Capsule-shape and has been identified as Quetiapine Fumarate Extended-Release 150 mg. It is supplied by Lupin Pharmaceuticals, Inc..

Quetiapine is used in the treatment of bipolar disorder; schizoaffective disorder; schizophrenia; depression; major depressive disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LU K72

Quetiapine Fumarate Extended-Release

Imprint
LU K72
Strength
150 mg
Color
White
Size
17.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc.
National Drug Code (NDC)
68180-0613
Inactive Ingredients
microcrystalline cellulose, hypromellose 2208 (15000 mPa.s), hypromellose 2910 (15000 mPa.s), hypromelloses, lactose monohydrate, magnesium stearate, polyethylene glycol 400, titanium dioxide, trisodium citrate dihydrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.